Free Trial

Nadine Sarwat Analyst Performance

Analyst at Sanford C. Bernstein

Nadine Sarwat is a stock analyst at Sanford C. Bernstein focused in the consumer staples sector, covering 6 publicly traded companies. Over the past year, Nadine Sarwat has issued 10 stock ratings, including buy and hold recommendations. While full access to Nadine Sarwat's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Nadine Sarwat's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
10 Last 0 Years
Buy Recommendations
20.00% 2 Buy Ratings
Companies Covered
6 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy20.0%2 ratings
Hold80.0%8 ratings
Sell0.0%0 ratings

Out of 10 total stock ratings issued by Nadine Sarwat at Sanford C. Bernstein, the majority (80.0%) have been Hold recommendations, followed by 20.0% Buy.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NYSE
83.3% of companies on NYSE
5 companies
NASDAQ
16.7% of companies on NASDAQ
1 company

Nadine Sarwat, an analyst at Sanford C. Bernstein, currently covers 6 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Consumer Staples
5 companies
83.3%
Medical
1 company
16.7%

Nadine Sarwat of Sanford C. Bernstein specializes in stock coverage within the Consumer Staples sector, with additional focus on Medical companies.

Coverage Industries

IndustryPercentage
BEVERAGES - ALCOH
5 companies
83.3%
MED - DRUGS
1 company
16.7%

Nadine Sarwat's Ratings History at Sanford C. Bernstein

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Brown-Forman Corporation stock logo
BF.B
Brown-Forman
3/9/2026Reiterated Rating$25.24$29.00Market Perform
Cronos Group Inc. stock logo
CRON
Cronos Group
1/14/2026Reiterated Rating$2.70$2.30Market Perform
Constellation Brands Inc stock logo
STZ
Constellation Brands
1/9/2026Boost Price Target$148.35$197.00Outperform
Ambev S.A. stock logo
ABEV
Ambev
11/26/2025Reiterated Rating$2.51$2.88Market Perform
Ambev S.A. stock logo
ABEV
Ambev
11/26/2025Downgrade$2.52$2.88Market Perform
Molson Coors Beverage Company stock logo
TAP
Molson Coors Beverage
11/5/2025Lower Price Target$45.21$50.00Market Perform
Constellation Brands Inc stock logo
STZ
Constellation Brands
9/4/2025Lower Price Target$145.50$195.00Outperform
The Boston Beer Company, Inc. stock logo
SAM
Boston Beer
7/28/2025Set Price Target$208.04$230.00Market Perform
The Boston Beer Company, Inc. stock logo
SAM
Boston Beer
7/9/2025Lower Price Target$198.12$230.00Market Perform